|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2007-11-21
|
|
pubmed:abstractText |
To assess the cost-effectiveness of chemoradiotherapy (CRT) regimens for patients with esophageal cancer, we compared two regimens consisting of 5-fluorouracil (5-FU) and cisplatin (CDDP) or 5-FU and nedaplatin (CDGP) with radiotherapy.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1807-13
|
|
pubmed:meshHeading |
pubmed-meshheading:18030014-Aged,
pubmed-meshheading:18030014-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18030014-Cisplatin,
pubmed-meshheading:18030014-Cost-Benefit Analysis,
pubmed-meshheading:18030014-Drug Administration Schedule,
pubmed-meshheading:18030014-Esophageal Neoplasms,
pubmed-meshheading:18030014-Female,
pubmed-meshheading:18030014-Fluorouracil,
pubmed-meshheading:18030014-Humans,
pubmed-meshheading:18030014-Male,
pubmed-meshheading:18030014-Markov Chains,
pubmed-meshheading:18030014-Middle Aged,
pubmed-meshheading:18030014-Organoplatinum Compounds,
pubmed-meshheading:18030014-Survival Rate
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].
|
|
pubmed:affiliation |
Dept. of Pathophysiology, Showa University School of Pharmaceutical Sciences.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
